Susquehanna International Group’s BioCardia BCDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.7K | Sell |
38,808
-21,141
| -35% | -$41.2K | ﹤0.01% | 5957 |
|
|
2025
Q1 | $152K | Buy |
59,949
+16,107
| +37% | +$40.9K | ﹤0.01% | 5676 |
|
|
2024
Q4 | $95.6K | Sell |
43,842
-26,754
| -38% | -$58.3K | ﹤0.01% | 5704 |
|
|
2024
Q3 | $220K | Buy |
70,596
+26,039
| +58% | +$81.2K | ﹤0.01% | 4706 |
|
|
2024
Q2 | $132K | Buy |
+44,557
| New | +$132K | ﹤0.01% | 4987 |
|
|
2024
Q1 | – | Sell |
-4,362
| Closed | -$43.5K | – | 5583 |
|
|
2023
Q4 | $43.5K | Buy |
+4,362
| New | +$43.5K | ﹤0.01% | 5570 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5571 |
|
|
2023
Q2 | – | Sell |
-2,913
| Closed | -$85.6K | – | 5664 |
|
|
2023
Q1 | $85.6K | Sell |
2,913
-4,609
| -61% | -$136K | ﹤0.01% | 5300 |
|
|
2022
Q4 | $236K | Sell |
7,522
-1,628
| -18% | -$51K | ﹤0.01% | 4248 |
|
|
2022
Q3 | $266K | Buy |
9,150
+1,894
| +26% | +$55.1K | ﹤0.01% | 4386 |
|
|
2022
Q2 | $161K | Buy |
7,256
+2,434
| +50% | +$54K | ﹤0.01% | 4720 |
|
|
2022
Q1 | $150K | Buy |
4,822
+436
| +10% | +$13.6K | ﹤0.01% | 4983 |
|
|
2021
Q4 | $128K | Buy |
4,386
+1,466
| +50% | +$42.8K | ﹤0.01% | 5206 |
|
|
2021
Q3 | $138K | Buy |
+2,920
| New | +$138K | ﹤0.01% | 4873 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5326 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5184 |
|
|
2019
Q4 | – | Sell |
-1,021
| Closed | -$51K | – | 4020 |
|
|
2019
Q3 | $51K | Buy |
+1,021
| New | +$51K | ﹤0.01% | 4197 |
|